(Q35689019)

9 August 2017

1 reference

title

Antifibrotic therapy in scleroderma: extracellular or intracellular targeting of activated fibroblasts? (English)

1 reference

9 August 2017

John Varga

1

1 reference

9 August 2017

1 April 2004

1 reference

Current Rheumatology Reports

9 August 2017

1 reference

9 August 2017

6

1 reference

9 August 2017

164-170

1 reference

9 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-004-0062-8

9 August 2017

0 references

cites work

Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-004-0062-8

Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-004-0062-8

Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis

21 January 2018

1 reference

12 December 2020

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

12 December 2020

Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis

1 reference

12 December 2020

Cytokines and anti-cytokine biologicals in autoimmunity: present and future

1 reference

12 December 2020

Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade

1 reference

12 December 2020

Role of monocyte chemoattractant protein-1 and its receptor,CCR-2, in the pathogenesis of bleomycin-induced scleroderma.

1 reference

12 December 2020

Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts.

1 reference

12 December 2020

1 reference

12 December 2020

Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies

1 reference

12 December 2020

Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.

1 reference

12 December 2020

Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency.

1 reference

12 December 2020

B-Myb acts as a repressor of human COL1A1 collagen gene expression by interacting with Sp1 and CBF factors in scleroderma fibroblasts

1 reference

12 December 2020

Mammary tumor suppression by transforming growth factor beta 1 transgene expression

1 reference

12 December 2020

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

1 reference

12 December 2020

Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene

1 reference

12 December 2020

The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis

1 reference

12 December 2020

Deficient Smad7 expression: a putative molecular defect in scleroderma

1 reference

12 December 2020

Molecular aspects of scleroderma

1 reference

12 December 2020

Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma

1 reference

12 December 2020

Role of transforming growth factor beta in human disease

1 reference

12 December 2020

Disruption of TGF-β signaling in T cells accelerates atherosclerosis

1 reference

12 December 2020

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

12 December 2020

Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts

1 reference

12 December 2020

Transforming growth factor beta s and wound healing

1 reference

12 December 2020

A nuclear target for interleukin-1alpha: interaction with the growth suppressor necdin modulates proliferation and collagen expression

1 reference

12 December 2020

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

1 reference

12 December 2020

TGF-beta: receptors, signaling pathways and autoimmunity

1 reference

12 December 2020

CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling

1 reference

12 December 2020

Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated

1 reference

12 December 2020

Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts

1 reference

12 December 2020

Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma

1 reference

12 December 2020

Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis

1 reference

12 December 2020

10.1007/S11926-004-0062-8

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

15016348